-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Cocrystal Pharma, Lowers Price Target to $7

Benzinga·08/22/2024 12:45:17
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cocrystal Pharma (NASDAQ:COCP) with a Buy and lowers the price target from $10 to $7.